Medicare Enrolled
Dr. Jascha Rubin, M.D.
Hematology & Oncology · Philadelphia, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rubin
Dr. Jascha Rubin is a hematology & oncology specialist in Philadelphia, PA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rubin performed 67,855 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rubin received a total of $11,788 from 82 pharmaceutical and/or device companies across 511 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rubin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 10% volume in PA
$11,788 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗67,855
Medicare services
Top 10% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
36,400 | $2 | $21 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
12,000 | $1 | $4 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
10,260 | $38 | $135 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
1,970 | $33 | $251 |
| Denosumab injection (Prolia/Xgeva) | 1,920 | $18 | $67 |
| Iron infusion (Monoferric) | 1,800 | $17 | $72 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
690 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
592 | $8 | $35 |
| Anti-nausea injection (Aloxi/palonosetron) | 370 | $1 | $122 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
216 | $137 | $301 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
204 | $86 | $879 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
170 | $11 | $93 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
140 | $99 | $224 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
118 | $13 | $105 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
109 | $51 | $304 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
103 | $1 | $7 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
97 | $61 | $205 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
93 | $108 | $686 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $62 | $148 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
65 | $107 | $297 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
63 | $65 | $157 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
54 | $98 | $231 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
42 | $17 | $97 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
40 | $24 | $152 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $132 | $343 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
33 | $1 | $9 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $136 | $412 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
27 | $23 | $156 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $86 | $219 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
23 | $70 | $251 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
18 | $1 | $19 |
| New patient office visit, complex (60-74 min) | 17 | $161 | $432 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
15 | $27 | $249 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
15 | $2 | $19 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
12 | $8 | $19 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
23.7% high complexity
74.2% medium
2.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,788
Total received (2018-2024)
Avg $1,684/year across 7 years
Top 20% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
511
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,089
2023
$1,624
2022
$389
2021
$395
2020
$495
2019
$2,724
2018
$3,072
Payments by company (2024)
Janssen Biotech, Inc.
$250
Novartis Pharmaceuticals Corporation
$250
Daiichi Sankyo Inc.
$199
AstraZeneca Pharmaceuticals LP
$182
Astellas Pharma US Inc
$164
Dendreon Pharmaceuticals LLC
$145
PFIZER INC.
$136
GlaxoSmithKline, LLC.
$136
Bayer Healthcare Pharmaceuticals Inc.
$126
ABBVIE INC.
$115
SOBI, INC
$100
Incyte Corporation
$99
Merck Sharp & Dohme LLC
$90
Genentech USA, Inc.
$89
GENZYME CORPORATION
$73
Eisai Inc.
$66
E.R. Squibb & Sons, L.L.C.
$64
Acrotech Biopharma Inc.
$52
Regeneron Healthcare Solutions, Inc.
$50
Genmab U.S., Inc.
$50
Gilead Sciences, Inc.
$47
Mirati Therapeutics, Inc.
$42
ADC Therapeutics America, Inc.
$41
Lilly USA, LLC
$35
Immunocore Limited
$35
Karyopharm Therapeutics Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$31
UROGEN PHARMA, INC.
$30
Novocure Inc.
$29
Ipsen Biopharmaceuticals, Inc
$29
ARRAY BIOPHARMA INC
$27
Tempus AI, Inc
$26
Alexion Pharmaceuticals, Inc.
$26
BeiGene USA, Inc.
$25
PUMA BIOTECHNOLOGY, INC.
$23
Pharmacosmos Therapeutics Inc.
$23
MorphoSys, US Inc.
$23
Amneal Pharmaceuticals LLC
$21
Rigel Pharmaceuticals, Inc.
$20
Aveo Pharmaceuticals, Inc.
$20
Adaptive Biotechnologies Corporation
$19
Stemline Therapeutics Inc.
$17
TerSera Therapeutics LLC
$17
Coherus Biosciences Inc.
$13
Top 3 companies account for 22.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,431
Janssen Biotech, Inc.
$898
E.R. Squibb & Sons, L.L.C.
$720
Novartis Pharmaceuticals Corporation
$626
Astellas Pharma US Inc
$582
PFIZER INC.
$450
Genentech USA, Inc.
$431
Daiichi Sankyo Inc.
$363
Amgen Inc.
$359
GENZYME CORPORATION
$299
Incyte Corporation
$277
Merck Sharp & Dohme Corporation
$263
Eisai Inc.
$258
Lilly USA, LLC
$249
Pharmacyclics LLC, An AbbVie Company
$249
Dendreon Pharmaceuticals LLC
$219
Kyowa Kirin, Inc.
$208
Celgene Corporation
$194
Bayer Healthcare Pharmaceuticals Inc.
$174
Boehringer Ingelheim Pharmaceuticals, Inc.
$172
Merck Sharp & Dohme LLC
$155
GlaxoSmithKline, LLC.
$152
TESARO, Inc.
$151
Takeda Pharmaceuticals U.S.A., Inc.
$141
Bayer HealthCare Pharmaceuticals Inc.
$138
Regeneron Healthcare Solutions, Inc.
$131
Agios Pharmaceuticals, Inc.
$131
ABBVIE INC.
$115
Kite Pharma, Inc.
$108
Rigel Pharmaceuticals, Inc.
$106
Gilead Sciences, Inc.
$100
SOBI, INC
$100
Foundation Medicine, Inc.
$87
Spectrum Pharmaceuticals Inc.
$85
INSYS Therapeutics Inc
$79
EMD Serono, Inc.
$77
AbbVie, Inc.
$75
Acrotech Biopharma Inc.
$74
Mirati Therapeutics, Inc.
$65
MorphoSys, US Inc.
$64
Seagen Inc.
$53
Ipsen Biopharmaceuticals, Inc
$52
Puma Biotechnology, Inc.
$51
Karyopharm Therapeutics Inc.
$51
Exelixis Inc.
$51
Genmab U.S., Inc.
$50
Taiho Oncology, Inc.
$49
JAZZ PHARMACEUTICALS INC.
$47
Pharmacosmos Therapeutics Inc.
$45
Verastem, Inc.
$45
Aurobindo Pharma USA, Inc.
$41
ADC Therapeutics America, Inc.
$41
Helsinn Therapeutics (U.S.), Inc.
$36
Immunocore Limited
$35
AVEO Pharmaceuticals, Inc.
$33
UROGEN PHARMA, INC.
$30
Pharmacyclics LLC, an AbbVie Company
$30
Novocure Inc.
$29
ARRAY BIOPHARMA INC
$27
Prometheus Laboratories Inc.
$27
Otsuka America Pharmaceutical, Inc.
$26
Tempus AI, Inc
$26
Alexion Pharmaceuticals, Inc.
$26
BeiGene USA, Inc.
$25
Octapharma USA, Inc.
$25
Dova Pharmaceuticals
$24
PUMA BIOTECHNOLOGY, INC.
$23
Jazz Pharmaceuticals Inc.
$21
Amneal Pharmaceuticals LLC
$21
Aveo Pharmaceuticals, Inc.
$20
Adaptive Biotechnologies Corporation
$19
Advanced Accelerator Applications
$18
Stemline Therapeutics Inc.
$17
TerSera Therapeutics LLC
$17
Global Blood Therapeutics, Inc.
$16
Seattle Genetics, Inc.
$16
Blueprint Medicines Corporation
$15
Teva Pharmaceuticals USA, Inc.
$15
EUSA Pharma (US) LLC
$14
Coherus Biosciences Inc.
$13
MEDIVATION FIELD SOLUTIONS LLC
$13
Sysmex Inostics Inc
$4
Top 3 companies account for 25.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AUGTYRO · AVASTIN · AYVAKIT · Alecensa · Avastin · BELEODAQ · BENDEKA · BOSULIF · BRUKINSA · Bavencio · CABLIVI · CALQUENCE · CARVYKTI · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FASLODEX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JELMYTO · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAPLAS · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Proleukin · REBLOZYL · Revlimid · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SPRYCEL · SUNOSI · SUTENT · SYNAGIS · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · Tecentriq · Tivdak · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Venclexta · Vitrakvi · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · XYNTHA · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZYTIGA · Zevalin · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
280
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rubin is a mixed practice specialist, with above-average Medicare volume (top 10% in PA), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rubin experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Rubin performed 36,400 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rubin receive payments from pharmaceutical companies?
Yes. Dr. Rubin received a total of $11,788 from 82 companies across 511 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubin's costs compare to other hematology & oncology specialists in Philadelphia?
Dr. Rubin's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Philadelphia
Browse hematology & oncology specialists in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology